Announcements Trials

Browse Landscape

Phase

Status

Completed 15 Terminated 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 185 Carboplatin 133 Paclitaxel 102 Cisplatin 102 Gemcitabine 86 Pemetrexed 80 durvalumab 75 Nivolumab 66 Docetaxel 56 atezolizumab 52 Bevacizumab 50 Cyclophosphamide 49 Dexamethasone 45 Capecitabine 45 Oxaliplatin 43 130-nm albumin-bound paclitaxel 42 Rituximab 40 Fulvestrant 39 Lenalidomide 38 Fluorouracil 38 Prednisone 32 osimertinib 31 olaparib 29 Leucovorin 29 venetoclax 28 fludarabine 28 Trastuzumab 27 Doxorubicin 27 Etoposide 25 Cetuximab 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × INDUSTRY × necitumumab × Clear all

NCT03944772 2025-01-30

ORCHARD

AstraZeneca

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡